JP2020517676A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020517676A5 JP2020517676A5 JP2019557759A JP2019557759A JP2020517676A5 JP 2020517676 A5 JP2020517676 A5 JP 2020517676A5 JP 2019557759 A JP2019557759 A JP 2019557759A JP 2019557759 A JP2019557759 A JP 2019557759A JP 2020517676 A5 JP2020517676 A5 JP 2020517676A5
- Authority
- JP
- Japan
- Prior art keywords
- oxy
- triazole
- acetamide
- isopropyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762490865P | 2017-04-27 | 2017-04-27 | |
| US62/490,865 | 2017-04-27 | ||
| PCT/EP2018/060800 WO2018197643A1 (en) | 2017-04-27 | 2018-04-26 | Phenoxyquinazoline compounds and their use in treating cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020517676A JP2020517676A (ja) | 2020-06-18 |
| JP2020517676A5 true JP2020517676A5 (https=) | 2021-04-22 |
| JP7117323B2 JP7117323B2 (ja) | 2022-08-12 |
Family
ID=62165533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019557759A Active JP7117323B2 (ja) | 2017-04-27 | 2018-04-26 | フェノキシキナゾリン化合物及び癌の処置におけるそれらの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11053223B2 (https=) |
| EP (1) | EP3615526B1 (https=) |
| JP (1) | JP7117323B2 (https=) |
| CN (1) | CN110546147B (https=) |
| CA (1) | CA3059660A1 (https=) |
| ES (1) | ES2887261T3 (https=) |
| WO (1) | WO2018197643A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX389244B (es) | 2017-04-27 | 2025-03-20 | Astrazeneca Ab | Compuestos de c5-anilinoquinazolina y su uso en el tratamiento del cancer |
| KR102674404B1 (ko) * | 2018-04-20 | 2024-06-13 | 엘지전자 주식회사 | 저온 저장고의 냉각 시스템 |
| KR102908062B1 (ko) * | 2023-11-16 | 2026-01-05 | (주)신테카바이오 | 헤테로아릴 유도체 화합물 및 이의 용도 |
| CN118772070B (zh) * | 2024-06-12 | 2025-12-16 | 天津济坤医药科技有限公司 | 一种喹唑啉衍生物及其制备方法和应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9510757D0 (en) * | 1994-09-19 | 1995-07-19 | Wellcome Found | Therapeuticaly active compounds |
| GB9514265D0 (en) * | 1995-07-13 | 1995-09-13 | Wellcome Found | Hetrocyclic compounds |
| GB9707800D0 (en) | 1996-05-06 | 1997-06-04 | Zeneca Ltd | Chemical compounds |
| US7709479B1 (en) * | 1999-09-21 | 2010-05-04 | Astrazeneca | Quinazoline derivatives and their use as pharmaceuticals |
| EP1652847B1 (en) * | 2001-04-27 | 2008-05-28 | Kirin Pharma Kabushiki Kaisha | Quinoline and quinazoline derivatives for the treatment of tumors |
| TW200505452A (en) * | 2003-06-17 | 2005-02-16 | Astrazeneca Ab | Chemical compounds |
| PT2213661E (pt) * | 2003-09-26 | 2011-12-15 | Exelixis Inc | Moduladores de c-met e métodos de uso |
| EP1802591B1 (en) * | 2004-10-12 | 2012-01-11 | AstraZeneca AB | Quinazoline derivatives |
| CN1313449C (zh) * | 2005-07-14 | 2007-05-02 | 沈阳中海生物技术开发有限公司 | 新的喹唑啉类衍生物、含有其的药物组合物以及它们的用途 |
| CN102267952B (zh) * | 2011-06-21 | 2013-12-11 | 天津市汉康医药生物技术有限公司 | 喹唑啉类化合物、其制备方法和用途 |
| CN103254142B (zh) * | 2013-04-26 | 2015-10-28 | 浙江工业大学 | 4-[4-(2-取代氨基乙酰氨基)苯胺基]喹唑啉类衍生物及制备和应用 |
| CN104130200B (zh) * | 2014-07-01 | 2016-04-20 | 中山大学 | 一种2-取代苯基-4-芳胺基喹唑啉衍生物及其制备方法和应用 |
-
2018
- 2018-04-26 WO PCT/EP2018/060800 patent/WO2018197643A1/en not_active Ceased
- 2018-04-26 CA CA3059660A patent/CA3059660A1/en active Pending
- 2018-04-26 US US16/608,212 patent/US11053223B2/en active Active
- 2018-04-26 CN CN201880027738.3A patent/CN110546147B/zh active Active
- 2018-04-26 JP JP2019557759A patent/JP7117323B2/ja active Active
- 2018-04-26 ES ES18724488T patent/ES2887261T3/es active Active
- 2018-04-26 EP EP18724488.4A patent/EP3615526B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6644792B2 (ja) | ベンザゼピンスルホンアミド化合物 | |
| TWI640509B (zh) | 製造喹啉化合物之方法及包含該化合物之醫藥組合物 | |
| KR102534262B1 (ko) | 헤테로환형 유도체 및 이의 용도 | |
| JP2022119990A (ja) | アポトーシス誘発剤 | |
| JP2020517676A5 (https=) | ||
| JP2020517677A5 (https=) | ||
| JP2020515574A5 (https=) | ||
| JP2017533968A5 (https=) | ||
| JP2020506951A5 (https=) | ||
| JP2020537657A5 (https=) | ||
| JP2019518766A5 (https=) | ||
| JP2016512823A5 (https=) | ||
| JP2015516420A5 (https=) | ||
| JPH06500117A (ja) | 抗腫瘍活性を増強させる２，４−ジアミノキナゾリン誘導体 | |
| JP2008505171A5 (https=) | ||
| JP2020502092A5 (https=) | ||
| JP2014523901A5 (https=) | ||
| JP2020517611A5 (https=) | ||
| JP2014524476A5 (https=) | ||
| JP2014501766A5 (https=) | ||
| JP2013533253A5 (https=) | ||
| JP2018520202A5 (https=) | ||
| WO2008117229A4 (en) | Muscarinic receptor antagonists | |
| JP2018513832A5 (https=) | ||
| JP2015508092A5 (https=) |